HPV persistence and CIN2 + Detection in women with normal cytology and Non-16/18 High-Risk HPV positivity
Open Access
- 20 January 2026
- journal article
- research article
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Abstract
The optimal management of women with non-16/18 hrHPV infection and normal cytology remains a topic of clinical debate. While immediate colposcopy is oftenKeywords
This publication has 17 references indexed in Scilit:
- The meaning of high‐risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?Diagnostic Cytopathology, 2021
- 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer PrecursorsJournal of Lower Genital Tract Disease, 2020
- Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus GuidelinesJournal of Lower Genital Tract Disease, 2020
- Immediate biopsy of cervical cytology‐negative and non‐HPV‐16/18 oncogenic types positive patientsDiagnostic Cytopathology, 2018
- HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV testBritish Journal of Cancer, 2017
- The Bethesda System for Reporting Cervical Cytology2015
- Development of therapeutic HPV vaccinesThe Lancet Oncology, 2009
- Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-AnalysisAmerican Journal of Epidemiology, 2008
- Chapter 9: Clinical applications of HPV testing: A summary of meta-analysesVaccine, 2006
- HPV infection and number of lifetime sexual partners are strong predictors for ‘natural’ regression of CIN 2 and 3British Journal of Cancer, 2003